linq header

THE FUTURE IS HERE. MEET the LINQ II™ system

The LINQ II™ insertable cardiac monitoring system is the world’s most accurate ICM,1-4 personalised for the patient’s lifestyle and customised for the clinician’s workflow.
LINQ II™ ICM is ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management.

reveal icon

reveal linq™
mobile manager

 

Exclusive app-based programmer that simplifies ICM procedure, enabling device activation, programming and CareLink™ pre-enrollment, all from your tablet.

linq icon

LINQ II™
INSERTABLE CARDIAC MONITOR

 

World’s most accurate1-4 ICM personalised for the patient’s lifestyle and customised for the clinician’s workflow.

carelink icon

MYCARELINK HEART™ MOBILE APP
OR
MYCARELINK RELAY™ 

HOME COMMUNICATOR


Two monitoring options
to fit patient lifestyle and address patients’ monitoring needs.

beconnected icon

BECONNECTED
PATIENT SERVICE

 

Phone support service dedicated to patients. Frees up clinic time by helping patients onboard with their optimal monitoring solution and answering device and monitoring questions. 

care link

CareLink™
Network

 

Patient monitoring network that enables data-driven care decisions, quickly and easily.

focuson icon

FocusOn™
Monitoring and Triaging Service

 

Service designed to help healthcare professionals save time spent reviewing transmissions whilst enabling better outcomes

streamlined cta

reimagined cta

unmatched cta

banner

Driving efficiencies at every step of the path to diagnosis.

REMOTE PROGRAMMING

LINQ II™ is the first ICM with remote programming capability*6:

  • Enables programming directly from clinic for all device parameters post-insertion
  • Enables on-going programming optimisation which reduces non-actionable transmissions
  • May reduce patient office visits and scheduling challenges  
remote programming

*First CE-marked ICM with remote programming capabilities.

SMART MEMORY MANAGEMENT

Efficient follow-up11 with full remote ECG access without need for manual transmissions6 and reduction of repetitive ECG12

smart memory

banner

ENHANCING DISEASE MANAGEMENT AND IMPROVING PATIENT EXPERIENCE

INCREASED DEVICE LONGEVITY UP TO 4.5 YEARS

4.5-year* longevity allows for increased disease management capabilities without sacrificing device size.6

device longevity

BLUESYNC™ TECHNOLOGY

The BlueSync™ technology inside LINQ II™ enables secure, wireless communication via Bluetooth® Low Energy for an improved remote monitoring experience.

KEY DESIGN CHANGES

key design changes

MONITORING PERSONALISED FOR PATIENT'S LIFESTYLE

Two different monitoring options to address your patients’ monitoring needs.

MYCARELINK HEART™ MOBILE APP*

MYCARELINK RELAY™
HOME COMMUNICATOR

monitoring options

banner

SIGNIFICANTLY REDUCING BURDEN
ASSOCIATED WITH EPISODE REVIEW.

TRURHYTHM DETECTION

Trurhythm Detection enables the lowest published rate of AF False positives1-4

detection image

Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.
*Based on AF episodes ≥ 2 minutes and in known AF patients.
% of false positives = (1 – episode PPV). AF episodes PPV may vary between gross and patient average.
† Confirm™ Rx with SharpSense™ technology & BIOMONITOR III have no published clinical evidence showing AF episode PPV or AF sensitivity.

When compared to other ICMs, LINQ II™ with TruRhythm™ detection provides up to:1,5

36-24 cta

23 12 cta

In a known AF patient population. % Full-time Employee 100 Patient Clinic, 40 hours per week, 44 weeks/year.

NEW PAUSE DETECTION ALGORITHM

The Pause Detection algorithm reduces burden due to false detection by addressing low amplitude, electrical noise and loss of contact.6

pause detection

NEW PAUSE DETECTION ALGORITHM

The algorithm uses both R-R interval and morphology characteristics to  distinguish a PVC beat from a normal beat.

pvc detection

*Please visit MCLHeart.com for a list of compatible smartphones and tablets.

References

1

Nölker G, et al. J Cardiovasc Electrophysiol. 2016;27:1403-1410.

2

Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.

3

Biotronik BioMonitor™ 2 Technical Manual. 2017.

4

Pürerfellner H, et al. Europace. 2018;20:f321-f328.

5

Rosemas S. AF Algorithm Clinic Efficiency. Medtronic data on file. April 2020. Based on Rogers J., et al. Circulation 140: A11947, Nölker 2016, Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017, Biotronik BioMonitor™ 2 Technical Manual 2017. Pürerfellner 2018

6

LINQ II LNQ22 ICM Clinician Manual. M974764A001D.

7

Medtronic data on file. 2019

8

Penela D, et al. J Am Coll Cardiol. 2013;62:1195-1202.

9

Penela D, et al. Heart Rhythm. 2017;14:1864-1870.

10

Reveal LINQ™ Clinician Manual. M958488A001

11

Alert Analysis for Reveal LINQ with TruRhythm and LINQ II. Medtronic data on file. 2020.

12

Van Heel L, et al. Circulation. 2019;140:A11830.